This study revealed the downregulation of METTL16 and YTHDF3 in patients with HbH disease, possibly due to the compensatory response of the body to reduce the aggregation of HbH inclusion bodies on the red blood cell membrane, which leads to a decrease in the plasticity of red blood cells. Here, METTL16 is linked to hemoglobin H disease.